Funded Tech Companies
Ra Pharmaceuticals
Looking for the VC firms that provided funding to Ra Pharmaceuticals? Amgen Ventures, Novartis Venture Fund and Novo Ventures put venture money into this biopharmaceutical company.
Company Overview
Company Name
Ra Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
87 Cambridge Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Company Background Information
Overview
Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma's peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/26/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Doug Treco
Chief Financial Officer
David Lubner
Chief Medical Officer
Ramin Farzaneh-Far
Chief Scientific Officer
Simon Read
VP - R & D
Alonso Ricardo
Company Investors
- Amgen Ventures
- Novartis Venture Fund (Markus Goebel)
- Novo Ventures (Peter Bisgaard)
- Morgenthaler Ventures
- Limulus Venture Partners
- New Enterprise Associates (Edward Mathers)
- Rock Springs Capital
- RA Capital (Rajeev Shah)
- Lightstone Ventures
- Morgenthaler Ventures (James Broderick)
Browse more funded tech companies:
R4 Vascular | RAAAM Memory Technologies
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs